ArticleNPJ breast cancer2023

Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer.

Alessandra Fabi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.